Clozapine Monitoring: New Guidelines for the Post-REMS Era
From Psychopharmacology and Psychiatry Updates · · 12 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
In this episode, we explore new international guidelines for clozapine monitoring following the FDA's REMS rescission. Should patients on stable clozapine continue lifelong monthly blood draws, or can we safely reduce monitoring after two years? Dr. Seeber discusses how these evidence-based recommendations balance patient burden with safety.
Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.
- Learn more about our membership here
- Earn 0.75 CMEs: Quick Take Vol. 79
- New Guidelines for Clozapine ANC Monitoring
Back to Psychopharmacology and Psychiatry Updates · Report a problem